Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.

NCT01687790 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01687790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2012
Completion date
September 30, 2014
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast abnormalities